Evidence mapPaperPMID 36434672Full record

ArticleResearch involvement and engagement2022

Stakeholder engagement in eight comparative effectiveness trials in African Americans and Latinos with asthma.

Tiffany Dy, Winifred J Hamilton, C Bradley Kramer, Andrea Apter, Jerry A Krishnan, James W Stout, Stephen J Teach, Alex Federman, John Elder, Tyra Bryant-Stephens and 3 more

Open access · goldAbstract read
In one paragraph

Article in Research involvement and engagement, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Tiffany DyDivision of Allergy and Immunology, Department of Internal Medicine, Washington University School of Medicine in St. Louis, 660 S. Euclid Ave, CB 8122, St. Louis, MO, 63110, USA. tdy@wustl.edu.
Winifred J HamiltonEnvironmental Health Service, Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX, USA.
C Bradley KramerPublic Health - Seattle & King County, Seattle, WA, USA.
Andrea ApterDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jerry A KrishnanDivision of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois Chicago and Population Health Sciences Program, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
James W StoutDepartment of Pediatrics and Health Services, University of Washington, Seattle, WA, USA.
Stephen J TeachDivision of Emergency Medicine and the Department of Pediatrics, Children's National Hospital, Washington, DC, USA.
Alex FedermanDivision of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
John ElderInstitute for Behavioral and Community Health, School of Public Health, San Diego State University, San Diego, CA, USA.
Tyra Bryant-StephensDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Rebecca J BruhlEnvironmental Health Service, Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX, USA.
Shawni JacksonDivision of General Medical Sciences, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Kaharu SuminoDivision of Pulmonary and Critical Care, Department of Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Baylor College of Medicine · USUniversity of Pennsylvania · USWashington University in St. Louis · USChildren's National · USIcahn School of Medicine at Mount Sinai · USPublic Health – Seattle & King County · USSan Diego State University · USUniversity of Illinois Chicago · USUniversity of Washington · US

Funding

Translational Research Support CoreP30ES013508 · UNIVERSITY OF PENNSYLVANIA · 2025 to 2025
$1.6M
NIEHS NIH HHS P30 ES013508Patient-Centered Outcomes Research Institute AS 1307-05218Patient-Centered Outcomes Research Institute AS-1307-05284Patient-Centered Outcomes Research Institute AS-1307-05420Patient-Centered Outcomes Research Institute AS-1307-05498Patient-Centered Outcomes Research Institute AS-1307-05584Patient-Centered Outcomes Research Institute AS-1307-05588Patient-Centered Outcomes Research Institute AS-1308-05876Patient-Centered Outcomes Research Institute AS-1308-05887
6 · The paper itself

Abstract

backgroundThe effects of stakeholder engagement, particularly in comparative effectiveness trials, have not been widely reported. In 2014, eight comparative effectiveness studies targeting African Americans and Hispanics/Latinos with uncontrolled asthma were funded by the Patient-Centered Outcomes Research Institute (PCORI) as part of its Addressing Disparities Program. Awardees were required to meaningfully involve patients and other stakeholders. Using specific examples, we describe how these stakeholders substantially changed the research protocols and in other ways participated meaningfully as full partners in the development and conduct of the eight studies.

methodsUsing the method content analysis of cases, we identified themes regarding the types of stakeholders, methods of engagement, input from the stakeholders, changes made to the research protocols and processes, and perceived benefits and challenges of the engagement process. We used summaries from meetings of the eight teams, results from an engagement survey, and the final research reports as our data source to obtain detailed information. The descriptive data were assessed by multiple reviewers using inductive and deductive qualitative methods and discussed in the context of engagement literature.

resultsStakeholders participated in the planning, conduct, and dissemination phases of all eight asthma studies. All the studies included clinicians and community representatives as stakeholders. Other stakeholders included patients with asthma, their caregivers, advocacy organizations, and health-system representatives. Engagement was primarily by participation in advisory boards, although six of the eight studies (75%) also utilized focus groups and one-on-one interviews. Difficulty finding a time and location to meet was the most reported challenge to engagement, noted by four of the eight teams (50%). Other reported challenges and barriers to engagement included recruitment of stakeholders, varying levels of enthusiasm among stakeholders, controlling power dynamics, and ensuring that stakeholder involvement was reflected and had true influence on the project.

conclusionEngagement-driven modifications led to specific changes in study design and conduct that were felt to have increased enrollment and the general level of trust and support of the targeted communities. The level of interaction described, between investigators and stakeholders in each study and between investigator-stakeholder groups, is-we believe-unprecedented and may provide useful guidance for other studies seeking to improve the effectiveness of community-driven research.

Indexed as

Asthma researchComparative effectiveness researchPatient-oriented researchStakeholder engagement

Identifiers

PMID36434672
PMCPMC9694541
OpenAlexW4309944436

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.